Technologies

0-9

A

• Amniocentesis Technologies

B

C

• Chorionic villus sampling Technologies
• Circulating tumour DNA for cancer patients Technologies
• Combined first-trimester screening Technologies
• Common aneuploidy testing (QF-PCR) Technologies

D

• Different approaches to gene sequencing Technologies
• Direct-to-consumer constitutional (germline) genomic testing Technologies

E

F

• Fluorescent in situ hybridisation (FISH) Technologies

G

• Gene panel sequencing Technologies

H

I

• Identity testing Technologies

J

K

• Karyotype Technologies

L

• Long-read sequencing Technologies

M

• Manchester (Evans) score Technologies
• Massively parallel sequencing Technologies
• Microarray (array CGH) Technologies
• Mitochondrial DNA testing Technologies
• Molecular tumour profiles for early breast cancer Technologies
• Multiplex ligation-dependent probe amplification (MLPA) Technologies
• Mutational signatures Technologies

N

• Newborn blood spot screening Technologies
• Next-generation sequencing Technologies
• Non-invasive prenatal diagnosis (NIPD) Technologies
• Non-invasive prenatal testing (NIPT) Technologies

O

P

• Preimplantation genetic testing Technologies
• Presymptomatic testing Technologies

Q

• Quadruple screening test Technologies

R

• R21: Rapid prenatal exome sequencing Technologies
• R22: Fetus with a likely chromosomal abnormality Technologies
• RNA sequencing (RNA-seq) Technologies

S

• Sanger sequencing Technologies
• Short tandem repeat (STR) testing Technologies
• Short-read sequencing Technologies
• Single gene sequencing Technologies
• Southern blotting Technologies

T

U

V

W

• Whole exome sequencing Technologies
• Whole genome sequencing Technologies

X

Y

Z